Point72 »

Enanta Pharmaceuticals shares owned by Point72

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Point72

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.2k 401 10.36

More positions owned by Point72

Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Broadcom Call Option (AVGO)
Cisco Systems Call Option (CSCO)
Nike CL B Call Option (NKE)
Deere & Company Call Option (DE)
Adobe Systems Incorporated (ADBE)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Bristol Myers Squibb Call Option (BMY)
Accenture Plc Ireland Shs Class A Call Option (ACN)
NVIDIA Corporation Call Option (NVDA)
McKesson Corporation (MCK)
Bruker Corporation (BRKR)
General Motors Company (GM)

View all positions for Point72

Top funds holding Enanta Pharmaceuticals

Farallon Capital Management
Vanguard Group
BlackRock
BlackRock
Krensavage Asset Management
Morgan Stanley
Armistice Capital
Marshall Wace
Acadian Asset Management
Soleus Capital Management
Bank of America Corporation
Citadel Advisors
Northern Trust
Renaissance Technologies
D. E. Shaw & Co

View all funds holding Enanta Pharmaceuticals